Danaher Corporation $DHR Shares Acquired by Baader Bank Aktiengesellschaft

Baader Bank Aktiengesellschaft lifted its stake in shares of Danaher Corporation (NYSE:DHR) by 22.1% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 9,606 shares of the conglomerate’s stock after acquiring an additional 1,741 shares during the period. Baader Bank Aktiengesellschaft’s holdings in Danaher were worth $1,740,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of the stock. Sumitomo Mitsui DS Asset Management Company Ltd raised its holdings in shares of Danaher by 3.9% during the 2nd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 85,472 shares of the conglomerate’s stock valued at $16,884,000 after buying an additional 3,195 shares during the period. Ayrshire Capital Management LLC raised its holdings in shares of Danaher by 3.0% during the 2nd quarter. Ayrshire Capital Management LLC now owns 34,039 shares of the conglomerate’s stock valued at $6,724,000 after buying an additional 982 shares during the period. Focus Financial Network Inc. raised its holdings in shares of Danaher by 8.4% during the 2nd quarter. Focus Financial Network Inc. now owns 8,208 shares of the conglomerate’s stock valued at $1,621,000 after buying an additional 639 shares during the period. Sovran Advisors LLC raised its holdings in shares of Danaher by 1.6% during the 2nd quarter. Sovran Advisors LLC now owns 4,759 shares of the conglomerate’s stock valued at $955,000 after buying an additional 76 shares during the period. Finally, Sivia Capital Partners LLC raised its holdings in shares of Danaher by 6.3% during the 2nd quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock valued at $397,000 after buying an additional 119 shares during the period. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Danaher

In other Danaher news, Director Teri List sold 2,778 shares of the business’s stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the transaction, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. The trade was a 11.81% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 11.10% of the company’s stock.

Danaher Trading Up 1.1%

Shares of DHR stock opened at $192.54 on Thursday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $279.90. The stock has a fifty day moving average of $200.61 and a two-hundred day moving average of $198.55. The firm has a market capitalization of $137.87 billion, a PE ratio of 40.97, a price-to-earnings-growth ratio of 2.66 and a beta of 0.75.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The company had revenue of $5.94 billion during the quarter, compared to analyst estimates of $5.83 billion. During the same quarter in the previous year, the firm posted $1.72 EPS. The firm’s quarterly revenue was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, research analysts expect that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be given a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Friday, September 26th. Danaher’s payout ratio is 27.23%.

Wall Street Analysts Forecast Growth

DHR has been the topic of several analyst reports. Evercore ISI dropped their target price on Danaher from $230.00 to $226.00 and set an “outperform” rating on the stock in a report on Tuesday, July 8th. Wall Street Zen upgraded Danaher from a “hold” rating to a “buy” rating in a report on Friday, June 27th. Scotiabank upgraded Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price objective on the stock in a report on Friday, July 11th. Barclays restated an “overweight” rating and set a $225.00 price objective (up from $215.00) on shares of Danaher in a report on Tuesday, June 24th. Finally, Deutsche Bank Aktiengesellschaft dropped their price objective on Danaher from $240.00 to $235.00 in a report on Thursday, June 5th. Seventeen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $246.35.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.